An Open-label, Ascending, Repeated Dose-finding Study of Sarilumab in Children and Adolescents With Polyarticular-course Juvenile Idiopathic Arthritis (pcJIA)
- Status
- COMPLETED
- Phase
- PHASE2
Clinical Trials Related to Regeneron Pharmaceuticals
Related studies linked through entity extraction aliases.
Study of REGN2810 in Patients With Advanced Cutaneous Squamous Cell Carcinoma
- Status
- COMPLETED
- Phase
- PHASE2
A Study to Assess the Efficacy and Safety of Dupilumab in Participants With Severe Atopic Dermatitis (AD) That Are Not Controlled With Oral Cyclosporine A (CSA) or for Those Who Cannot Take Oral CSA Because it is Not Medically Advisable
- Status
- COMPLETED
- Phase
- PHASE3
Safety and Activity Study of PSCA-Targeted CAR-T Cells (BPX-601) in Subjects With Selected Advanced Solid Tumors
- Status
- TERMINATED
- Phase
- PHASE1
Study of the Blood Concentrations of Two Formulations of REGN1033 in Healthy Subjects
- Status
- COMPLETED
- Phase
- PHASE1
Study of the Efficacy and Safety of Intravitreal (IVT) Aflibercept for the Improvement of Moderately Severe to Severe Nonproliferative Diabetic Retinopathy (NPDR)
- Status
- COMPLETED
- Phase
- PHASE3
Evaluation of Alirocumab Versus Ezetimibe on Top of Statin in Asia in High Cardiovascular Risk Patients With Hypercholesterolemia
- Status
- COMPLETED
- Phase
- PHASE3
Anti-angiOpoeitin 2 Plus Anti-vascular eNdothelial Growth Factor as a therapY for Neovascular Age Related Macular Degeneration: Evaluation of a fiXed Combination Intravitreal Injection
- Status
- COMPLETED
- Phase
- PHASE2
Anti-vasculaR Endothelial Growth Factor plUs Anti-angiopoietin 2 in Fixed comBination therapY: Evaluation for the Treatment of Diabetic Macular Edema
- Status
- COMPLETED
- Phase
- PHASE2
EAGLE: Evaluating Genotypes Using Intravitreal Aflibercept Injection
- Status
- COMPLETED
- Phase
- PHASE4
Long-Term Safety and Efficacy Study of Fasinumab in Patients With Pain Due to Osteoarthritis (OA) of the Knee or Hip
- Status
- COMPLETED
- Phase
- PHASE3
Clinical Study of CMP-001 in Combination With Pembrolizumab or as a Monotherapy
- Status
- COMPLETED
- Phase
- PHASE1
A Study to Learn How Safe and Tolerable Odronextamab and Cemiplimab Are in Adult Patients With B-cell Malignancies
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1
Open Label, Drug-Drug Interaction (DDI) Study of Dupilumab (REGN668/SAR231893) in Patients With Moderate to Severe Atopic Dermatitis (AD)
- Status
- COMPLETED
- Phase
- PHASE1
Retrospective Data Analysis of Patients Treated for Macular Edema Due to Central Retinal Vein Occlusion
- Status
- COMPLETED
- Phase
- N/A
Efficacy and Safety of Alirocumab Versus Usual Care on Top of Maximally Tolerated Statin Therapy in Patients With Type 2 Diabetes and Mixed Dyslipidemia (ODYSSEY DM-Dyslipidemia)
- Status
- COMPLETED
- Phase
- PHASE4
Anti-VEGF Treatment for Prevention of PDR/DME
- Status
- COMPLETED
- Phase
- PHASE3
Clinical Research Platform Into Molecular Testing, Treatment and Outcome of (Non-)Small Cell Lung Carcinoma Patients
- Status
- RECRUITING
- Phase
- N/A
A Study to Determine the Efficacy and Safety of Fasinumab for the Treatment of Adults With Chronic Low Back Pain
- Status
- COMPLETED
- Phase
- PHASE2/PHASE3
Study to Assess the Long-term Safety of Dupilumab Administered in Participants ≥6 Months to <18 Years of Age With Atopic Dermatitis (AD)
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE3